There are very few patients who cannot have EECP. The individuals who should not be treated include pregnant women, those with a severe aneurysm (thinned & bulging vessel walls) in their aorta requiring surgical repair, and patients with active blood clots in their legs.

EECP is a US-FDA approved, Noninvasive (Non-Surgical), clinically proved, safe and effective and atraumatic procedure that can reduce the symptoms of angina pectoris, presumably by increasing coronary blood flow in ischemic areas of the heart. The procedure is administered in an out patient setting, does not require surgery and anesthesia and relatively comfortable for patient.

Documented research has shown benefits lasting three to five years after EECP treatment. These benefits include less anginal episodes, decreased nitroglycerin usage, increased blood flow on stress tests, and increased exercise tolerance.

No. Patients as young as thirty-six and as old as ninety-five have successfully completed EECP without any complications. Many of our patients are in their eighties and older and have excellent results.

Yes. EECP and ECP are significantly different. EECP is a registered trademark of Vasomedical, Inc., the leading manufacturer of EECP equipment in the U.S. Vasomedical has a patent on the timing mechanism, which determines the cuff inflation and deflation, and the cuff design — both specially designed to maximize augmentation — the most important part of the treatment.

Arterial Clearance Therapy (ACT) improves the arterial elasticity and improves the blood flow in the arteries by softening the calcified plaques. It also releases high no of antioxidants, which corrects the cellular damage in the arteries. Enhanced External counter Pulsation (EECP) opens up the complete collateral circulation of the heart. The micro vessels mostly capillaries lies dormant, EECP activates them. Thus the hearts do not have to depend on blood supply only on the three main arteries.

No. Our bodies follow the laws of physics, and one principle law is that fluid will travel in the path of least resistance. Atherosclerotic plaques are calcified and hard, and they create an obstruction that detours the blood through alternate routes. During EECP, when your blood is flowing to the heart, it will naturally bypass arteries with plaque and enter healthy, non-diseased blood vessels to go around blockages.

EECP was FDA approved in 1995 for the treatment of coronary artery disease and angina, cardiogenic shock, and for use during a heart attack. In 2002, the FDA approved EECP as a treatment for congestive heart failure. EECP has undergone clinical trials at leading universities around the nation and been subject to over a hundred scientific studies published in the most prestigious medical journals throughout the world.

Yes. Most patients have had at least one of these procedures. They come for EECP because they still experience cardiovascular symptoms.

EECP enhances blood flow to the heart and coronary arteries by squeezing blood out of the lower parts of the body up towards the heart. It is also called “Natural By Pass” .EECP stimulate the growth of new blood vessels (collateral Formation) around blocked arteries. Pair of three adjustable cuffs are wrapped around your calves, lower thigh and upper thigh including buttocks.

Published reports have found that EECP is a relatively safe and effective option for certain people with angina. The Multicenter Study of Enhanced External Counterpulsation (MUST-EECP) randomly assigned 139 people with angina from seven US hospitals to receive either active EECP or a placebo (inactive) procedure for 35 hours over four to seven weeks. About two-thirds of the people receiving EECP benefited from the treatment.

Enhanced External Counter Pulsation (EECP) is a non-invasive, atraumatic procedure that can reduce the symptoms of angina pectoris, presumably by increasing coronary bloodflow in ischemic areas of the heart. The beneficial effects of EECP on perfusion of the ischematic myocardium in patients with coronary artery disease appear to be sustained between treatments, and may persist long after completion of a course of therapy.